London — Thousands of people in the United Kingdom have filed a joint legal claim estimated to be worth more than £1 billion ($1.34 billion) against Johnson & Johnson,…
Read more Johnson & Johnson faces claim by 3,000 in U.K. who say asbestos in talcum powder made them sickJohnson & Johnson has reached tentative agreement to resolve talc baby powder claims with more than 40 states, the world’s biggest maker of health care products confirmed on…
Read more Johnson & Johnson reaches tentative deal to resolve talc baby powder litigationA New Jersey court has tossed a nearly $224 million verdict against Johnson & Johnson that was awarded to four people who alleged in a lawsuit that they…
Read more Court dismisses $224 million verdict against Johnson & Johnson in talcum power lawsuitU.S. stocks finished mostly lower Thursday, with the Nasdaq and S&P 500 dragged down by disappointing earnings, while the Dow Jones Industrial Average rose for a ninth straight…
Read more Dow posts longest winning streak in nearly 6 years; Nasdaq slumps over 2%IPO investors, much like retail shoppers in recent years’ inflationary environment, are demanding clear discounts and demonstrating sensitivity to price and valuations, according to Renaissance Capital. The provider…
Read more Like choosy shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivityEli Lilly & Co.’s market cap neared Johnson & Johnson’s market cap on Friday, as the stock has benefited from a slew of positive data in trials for…
Read more Eli Lilly nears J&J market capKenvue Inc. shares KVUE, +18.86% were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ, -0.24% spinoff, with consumer brands including Tylenol, Band-Aid and…
Read more Kenvue stock opens 16% above IPO, valuing the company at $47.7 billionA unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares were priced near the top of…
Read more Johnson & Johnson’s Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021Johnson & Johnson said Tuesday that it will offer at least $8.9 billion to resolve thousands of lawsuits filed by people alleging that the company’s products containing talc…
Read more Johnson & Johnson offers nearly $9 billion to settle talc lawsuitsJohnson & Johnson JNJ, +1.05% stock rose nearly 3% in the extended session Tuesday after the company said it was setting aside $8.9 billion to settle claims connected…
Read more Johnson & Johnson stock up 3% as company sets aside $8.9 billion to settle talc claimsA few days into the first Lunar New Year holiday since the lifting of pandemic restrictions in China, Chinese consumers are eager to travel but are also wary…
Read more China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is pastThe Food and Drug Administration is recommending that the U.S. decide each June which SARS-CoV-2 strains should be included in an annual fall booster shot. Doing so would…
Read more FDA backs annual COVID vaccine for Americans with strain to be decided midyearIt has taken just one day for Tesla Inc.’s stock to erase the entire bounce it enjoyed over the last three days trading sessions of 2022, as disappointing…
Read more Tesla stock wipes out three-day bounce, falls to lowest price in more than 2 yearsAmgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare autoimmune diseases, in a deal valued at $26.4 billion. Each Horizon shareholder will receive…
Read more Amgen to buy Horizon Therapeutics in $26.4 billion dealThe Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that the authority for…
Read more CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decision
